Review of Dr. Agarwal’s Health Care Limited IPO : Lot Size, Check Issue Date, Price

Dr. Agarwal’s Health Care IPO Price: ₹382 to ₹402 per share
IPO Dates: 29 January 2025 – 31 January 2025

Operational Network and Reach

As of September 30, 2024, the company operates 193 facilities across 14 states and four union territories in India, covering 117 metro and non-metro cities. This network is based on a hub-and-spoke model, consisting of 28 hubs (including three Centers of Excellence) and 165 spokes (53 primary and 112 secondary facilities). Internationally, the company has 16 facilities across nine African countries. Additionally, Dr. Agarwal’s Health Care is recognized for its NABH-accredited facilities, with 29 accredited centers as of December 2024.

Clinical and Operational Excellence

The company is known for its end-to-end, comprehensive eye care offerings. It specializes in various super-specialties, including cataract, cornea, retina, refractive surgery, glaucoma, oculoplasty, and neuro-ophthalmology. By September 2024, 737 doctors were providing care across its facilities. During FY 2024, Dr. Agarwal’s served 2.13 million patients and performed 220,523 surgeries. In the six months ending September 30, 2024, it served 1.15 million patients and conducted 140,787 surgeries.

Key Services

1. Cataract Surgeries: The company offers advanced cataract treatments, including small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments.
2. Refractive Surgeries: These procedures aim to correct refractive errors and reduce dependence on glasses or contact lenses. Key options include LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).
3. Other Surgeries: The company provides treatments such as surgical retinal procedures, corneal transplantation, pinhole pupilloplasty, oculoplasty, and surgeries for glaucoma and pterygium.

Market Leadership

Dr. Agarwal’s Health Care holds approximately 25% of the total eye care service chain market in India as of FY 2024, with revenue nearly 1.7 times higher than the second-largest eye care chain.

Competitive Strengths

• Proven Growth Record: The company has consistently demonstrated organic growth, successfully integrated acquisitions, scaled operations, and improved profitability.
• Market Leadership: India’s largest eye care services provider by revenue with a trusted brand reputation.
• Comprehensive Service Offering: The company provides a wide range of eye care solutions, ensuring end-to-end services.
• Efficient Operating Model: A scalable and asset-light hub-and-spoke model enables efficient delivery of services.
• Clinical Excellence: The company’s strong clinical board and history of surgical innovations drive its reputation for excellence.
• Experienced Leadership: Doctor-promoters lead a team of qualified medical professionals supported by experienced management.

Bidding Starts In

Dr. Agarwal’s Health Care IPO Specifics:

Dr. Agarwal’s Health Care IPO Timetable (Important Dates)

Dr. Agarwal’s Health Care IPO Lot Size

Bidders have the opportunity to bid for a minimum of 35 shares, with the option to increase in multiples. The table below outlines the minimum and maximum investment thresholds for both retail investors and High Net Worth Individuals (HNIs), specifying the corresponding number of shares and amounts involved.

Dr. Agarwal’s Health Care IPO Reservation

Dr. Agarwal’s Health Care Limited IPO Financial Information

Key Performance Indicator – Dr. Agarwal’s Health Care IPO

Objects of the Issue:

The company plans to utilize the net proceeds from the fresh issue for the following purposes:

• Partial or full repayment/prepayment of certain borrowings.
• General corporate purposes and potential unidentified inorganic acquisitions.

Prospectus Links:

Prospectus: Official documents that provide detailed information about the IPO and the company.